Bosentan Tablet 62.5 mg and 125 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 62.5 mg and 125 mg
Reference Brands: Tracleer®(US & EU)
Category: Orphan Drugs
Bosentan is an endothelin receptor antagonist that blocks the effects of endothelin-1, a substance causing blood vessel constriction. It relaxes pulmonary arteries, reducing blood pressure in PAH. Benefits include improved exercise capacity, decreased symptoms, and slowed disease progression in pulmonary arterial hypertension patients.
Product Description: Bosentan tablets, marketed as Tracleer®, are approved in the US and EU for pulmonary arterial hypertension. Regulatory dossiers include extensive clinical trials, manufacturing compliance, and safety data, facilitating approval by FDA and EMA. These dossiers highlight bosentan’s efficacy in improving exercise capacity and reducing symptoms of PAH. The medication is available in 62.5 mg and 125 mg tablets, with dosing titrated based on patient response. For detailed insights on regulatory submissions, dossier requirements, and market approvals, visit PharmaTradz, your trusted source for pharmaceutical regulatory insights and industry updates.
Bosentan Tablet — third party manufacturing & bulk supply
Bosentan Tablet 62.5 mg and 125 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Bosentan Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Bosentan Tablet →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Pasireotide Diaspartate
Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg
Form: Injection
Reference Brands: Signifor (USA/EU)
View Details
Sepiapterin
Strength:
1000 mg, 250 mg
Form: Tablets / oral powder
Reference Brands: Sephience (USA/EU)
View Details
Glycerol Phenylbutyrate
Strength:
1.1 g/mL
Form: Oral Solution
Reference Brands: Ravicti (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
